Rationale: In addition to the overwhelming lung inflammation that prevails in coronavirus
disease 2019 (COVID-19), hypercoagulation and thrombosis contribute to the lethality of …

In December 2019, the novel betacoronavirus Severe Acute Respiratory Disease Coronavirus
2 (SARS-CoV-2) was first detected in Wuhan, China. SARS-CoV-2 has since become a …

In the absence of an effective vaccine to prevent COVID-19 it is important to be able to track
community infections to inform public health interventions aimed at reducing the spread and …

Objectives Antibody testing against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
has been instrumental in detecting previous exposures and analyzing vaccine‐…

Background Antibodies raised against human seasonal coronaviruses (sCoVs), which are
responsible for the common cold, are known to cross-react with SARS-CoV-2 antigens. This …

Accurate characterization of extracellular vesicles (EVs) is critical to explore their diagnostic
and therapeutic applications. As the EV research field has developed, so too have the …

Myotonic dystrophy type 1 (DM1) is caused by an unstable CTG expansion in the 3′
untranslated region (3′UTR) of the myotonic dystrophy protein kinase gene (DMPK). Transcripts …

Small interfering RNA (siRNA) duplexes induce the specific cleavage of target RNAs in
mammalian cells. Their involvement in down-regulation of gene expression is termed RNA …

Several members of the apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like
complex 3 (APOBEC3) family in primates act as potent inhibitors of retroviral replication. …

Population-level immune surveillance, which includes monitoring exposure and assessing
vaccine-induced immunity, is a crucial component of public health decision-making during a …